| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥4.97B | ¥5.14B | -3.3% |
| Cost of Sales | ¥2.01B | ¥1.29B | +55.9% |
| Gross Profit | ¥2.96B | ¥3.85B | -23.1% |
| SG&A Expenses | ¥3.00B | ¥2.64B | +13.9% |
| Operating Income | ¥-36M | ¥1.22B | -103.0% |
| Non-operating Income | ¥12M | ¥4M | +190.0% |
| Non-operating Expenses | ¥2M | ¥18M | -90.9% |
| Ordinary Income | ¥-26M | ¥1.20B | -102.2% |
| Profit Before Tax | ¥-23M | ¥1.20B | -101.9% |
| Income Tax Expense | ¥-9M | ¥389M | -102.4% |
| Net Income | ¥-14M | ¥815M | -101.7% |
| Net Income Attributable to Owners | ¥-13M | ¥814M | -101.6% |
| Total Comprehensive Income | ¥-14M | ¥814M | -101.7% |
| Depreciation & Amortization | ¥38M | ¥34M | +10.9% |
| Interest Expense | ¥2M | ¥406,000 | +312.8% |
| Basic EPS | ¥-0.80 | ¥45.79 | -101.7% |
| Diluted EPS | ¥45.44 | ¥45.44 | +0.0% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥7.29B | ¥7.73B | ¥-436M |
| Cash and Deposits | ¥5.36B | ¥5.87B | ¥-517M |
| Accounts Receivable | ¥1.50B | ¥1.61B | ¥-116M |
| Non-current Assets | ¥2.68B | ¥799M | +¥1.88B |
| Property, Plant & Equipment | ¥421M | ¥201M | +¥220M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-89M | ¥589M | ¥-677M |
| Investing Cash Flow | ¥-687M | ¥-232M | ¥-455M |
| Financing Cash Flow | ¥259M | ¥-336M | +¥595M |
| Free Cash Flow | ¥-776M | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | -0.3% |
| Gross Profit Margin | 59.6% |
| Current Ratio | 366.1% |
| Quick Ratio | 366.1% |
| Debt-to-Equity Ratio | 0.53x |
| Interest Coverage Ratio | -21.48x |
| EBITDA Margin | 0.0% |
| Effective Tax Rate | 39.9% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -3.3% |
| Operating Income YoY Change | +25.6% |
| Ordinary Income YoY Change | +23.9% |
| Net Income Attributable to Owners YoY Change | +30.2% |
| Total Comprehensive Income YoY Change | +29.4% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 17.83M shares |
| Treasury Stock | 500K shares |
| Average Shares Outstanding | 17.32M shares |
| Book Value Per Share | ¥377.17 |
| EBITDA | ¥2M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥30.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| DentalDistribution | ¥736M | ¥-60M |
| DxDistribution | ¥97M | ¥28M |
| MedicalPlatform | ¥2.41B | ¥803M |
| SmartClinic | ¥1.50B | ¥175M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥11.33B |
| Operating Income Forecast | ¥477M |
| Ordinary Income Forecast | ¥482M |
| Net Income Attributable to Owners Forecast | ¥417M |
| Basic EPS Forecast | ¥24.11 |
| Dividend Per Share Forecast | ¥30.00 |
| Intangible Assets | ¥1.09B | ¥2M | +¥1.09B |
| Goodwill | ¥1.07B | - | - |
| Total Assets | ¥9.97B | ¥8.53B | +¥1.44B |
| Current Liabilities | ¥1.99B | ¥1.49B | +¥503M |
| Accounts Payable | ¥299M | ¥160M | +¥139M |
| Non-current Liabilities | ¥1.44B | ¥39M | +¥1.40B |
| Long-term Loans | ¥677M | - | - |
| Total Liabilities | ¥3.43B | ¥1.53B | +¥1.91B |
| Total Equity | ¥6.54B | ¥7.00B | ¥-463M |
| Capital Stock | ¥778M | ¥774M | +¥3M |
| Capital Surplus | ¥678M | ¥674M | +¥3M |
| Retained Earnings | ¥5.21B | ¥5.74B | ¥-533M |
| Treasury Stock | ¥-641M | ¥-641M | ¥0 |
| Owners' Equity | ¥6.03B | ¥6.55B | ¥-527M |
| Working Capital | ¥5.30B | - | - |